DLG4-related synaptopathy
Last updated 3 Nov 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
DLG4-related synaptopathy is a condition that affects neurological development. This condition is characterised by delayed development and mild to moderate intellectual disabilities that typically becomes evident before age 2. Over time, many individuals with DLG4-related synaptopathy lose skills that they have learned, such as speech or motor skills. About 20 percent of people with this condition cannot speak. Affected individuals often have neurodevelopmental disorders, such as autism spectrum disorder or attention-deficit/hyperactivity disorder. About half of individuals with this condition have recurrent seizures (epilepsy) that typically begin in childhood. Brain changes can also occur. These include brain tissue loss (atrophy) and abnormalities of the tissue connecting the left and right halves of the brain (corpus callosum) or the hippocampus, which is a region of the brain that is involved in learning and memory.
Description
DLG4-related synaptopathy is a condition that affects neurological development. This condition is characterised by delayed development and mild to moderate intellectual disabilities that typically becomes evident before age 2. Over time, many individuals with DLG4-related synaptopathy lose skills that they have learned, such as speech or motor skills. About 20 percent of people with this condition cannot speak. Affected individuals often have neurodevelopmental disorders, such as autism spectrum disorder or attention-deficit/hyperactivity disorder. About half of individuals with this condition have recurrent seizures (epilepsy) that typically begin in childhood. Brain changes can also occur. These include brain tissue loss (atrophy) and abnormalities of the tissue connecting the left and right halves of the brain (corpus callosum) or the hippocampus, which is a region of the brain that is involved in learning and memory.
Individuals with DLG4-related synaptopathy can also have weak muscle tone (hyptonia), loose joints (joint laxity), or a spine that curves to the side (scoliosis). Movement problems, including impaired muscle coordination (ataxia), involuntary muscle coordination (dystonia), or rhythmic shaking (tremor) are common in people with this condition. Other problems can include migraine, sleep problems, or anxiety. Some people with DLG4-related synaptopathy have a distinctive body type that includes a long face, slim body, and long fingers.
Less commonly, DLG4-related synaptopathy can affect a person's vision. Affected individuals can have eyes that do not point in the same direction (strabismus), farsightedness (hyperopia), or involuntary movements of the eyes (nystagmus). Some affected individuals have blindness because the area of the brain responsible for processing vision is impaired.
DLG4-related synaptopathy can also cause gastrointestinal difficulties that make it difficult to eat. These can include a backflow of stomach acids into the esophagus (gastroesophageal reflux disease or GERD).
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant+New variant. More than one pattern can apply in different cases.
Related genes
Other names
Intellectual developmental disorder 62
intellectual developmental disorder, autosomal dominant 62
SHINE syndrome
sleep disturbances, hypotonia, intellectual disability, neurologic disorder, and epilepsy syndrome
Related patient information and medicines

Patient information leaflet
Oral hygiene
Gently scrap. Use a fresh piece of floss each time. Some people prefer floss tape which slides between teeth more easily than normal floss. Also, some people use disposable plastic forks with a small length of floss between the two prongs. These may be easier to hold and manipulate. However, they are expensive. Some people use sticks, or small.

Patient information leaflet
Polymyalgia rheumatica
This is not a routine test for PMR but may be used if the diagnosis is not clear. What is the treatment for polymyalgia rheumatica. Steroids A steroid medicine Oral steroids such as prednisolone Prednisolone is the usual treatment. Are there any complica... Between 1 and 2 in every 10 people with PMR also develop a related condition called giant.

Patient information leaflet
Dengue
It is. How common is it in the UK? 300-400 cases of dengue occur each year in the UK, in travellers returning from countries where dengue is common. It is likely that other mild cases may go undetected. This list is... Your doctor will want to talk about where you have been, what exposure you have had to biting insects, what vaccinations you have.

Patient information leaflet
Costochondritis
Costochondritis is a painful chest wall condition, caused by localised inflammation in the joints of the rib cage.

Patient information leaflet
Earache
Dr Sarah Jarvis MBE The following may help people who devel... For more information, go to [https://patient.info/health/health-advice-for-travel-abroad/ears-and-flying](https://patient.info/health/health-advice-for-travel-abroad/ears-and-flying) Boils, spots and pimples Boils, spots and pimples can occur on the ear just like anywhere else on your.

Patient information leaflet
Can I take Lansoprazole and Quetiapine together?
Taking lansoprazole and quetiapine together may increase the risk of a rare but serious heart rhythm problem. It can also potentially change how much quetiapine is absorbed into your body. Why this happens Lansoprazole Lansoprazole to reduce stomach acid reduces stomach acid, which can change how quetiapine Quetiapine dissolves and is absorbed. By.
Further reading and references
- DLG4-related synaptopathy; MedlinePlus, National Library of Medicine.
- Levy AM, Gomez-Puertas P, Tumer Z. Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners. Int J Mol Sci. 2022 Apr 15;23(8):4390. doi: 10.3390/ijms23084390.
- Rodriguez-Palmero A, Boerrigter MM, Gomez-Andres D, Aldinger KA, Marcos-Alcalde I, Popp B, Everman DB, Lovgren AK, Arpin S, Bahrambeigi V, Beunders G, Bisgaard AM, Bjerregaard VA, Bruel AL, Challman TD, Cogne B, Coubes C, de Man SA, Denomme-Pichon AS, Dye TJ, Elmslie F, Feuk L, Garcia-Minaur S, Gertler T, Giorgio E, Gruchy N, Haack TB, Haldeman-Englert CR, Haukanes BI, Hoyer J, Hurst ACE, Isidor B, Soller MJ, Kushary S, Kvarnung M, Landau YE, Leppig KA, Lindstrand A, Kleinendorst L, MacKenzie A, Mandrile G, Mendelsohn BA, Moghadasi S, Morton JE, Moutton S, Muller AJ, O'Leary M, Pacio-Miguez M, Palomares-Bralo M, Parikh S, Pfundt R, Pode-Shakked B, Rauch A, Repnikova E, Revah-Politi A, Ross MJ, Ruivenkamp CAL, Sarrazin E, Savatt JM, Schluter A, Schonewolf-Greulich B, Shad Z, Shaw-Smith C, Shieh JT, Shohat M, Spranger S, Thiese H, Mau-Them FT, van Bon B, van de Burgt I, van de Laar IMBH, van Drie E, van Haelst MM, van Ravenswaaij-Arts CM, Verdura E, Vitobello A, Waldmuller S, Whiting S, Zweier C, Prada CE, de Vries BBA, Dobyns WB, Reiter SF, Gomez-Puertas P, Pujol A, Tumer Z. DLG4-related synaptopathy: a new rare brain disorder. Genet Med. 2021 May;23(5):888-899. doi: 10.1038/s41436-020-01075-9. Epub 2021 Feb 17.
- Tumer Z, Dye TJ, Prada C, White-Brown AM, MacKenzie A, Levy AM. DLG4-Related Synaptopathy. 2023 Jun 22. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK592682/
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

